These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8499891)

  • 1. Probiotic use of lactobacilli in the human female urogenital tract.
    McGroarty JA
    FEMS Immunol Med Microbiol; 1993 Apr; 6(4):251-64. PubMed ID: 8499891
    [No Abstract]   [Full Text] [Related]  

  • 2. Probiotic agents to protect the urogenital tract against infection.
    Reid G
    Am J Clin Nutr; 2001 Feb; 73(2 Suppl):437S-443S. PubMed ID: 11157354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lactobacilli and probiotics in maintaining vaginal health.
    Borges S; Silva J; Teixeira P
    Arch Gynecol Obstet; 2014 Mar; 289(3):479-89. PubMed ID: 24170161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
    Zárate G; Nader-Macias ME
    Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis.
    Pybus V; Onderdonk AB
    Microbes Infect; 1999 Apr; 1(4):285-92. PubMed ID: 10602662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the biological properties of vaginal lactobacilli in colonization process].
    Cherkasov SV; Zabirova TM; Sbignev AV; Cherkasov IV
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (4):61-4. PubMed ID: 12966881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells.
    Osset J; Bartolomé RM; García E; Andreu A
    J Infect Dis; 2001 Feb; 183(3):485-91. PubMed ID: 11133381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli.
    Delley M; Bruttin A; Richard M; Affolter M; Rezzonico E; Brück WM
    FEMS Microbiol Lett; 2015 Jul; 362(13):fnv096. PubMed ID: 26078118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
    Barrons R; Tassone D
    Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role played by lactobacilli in controlling the population of vaginal pathogens.
    Boris S; Barbés C
    Microbes Infect; 2000 Apr; 2(5):543-6. PubMed ID: 10865199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotic strategies for the treatment and prevention of bacterial vaginosis.
    MacPhee RA; Hummelen R; Bisanz JE; Miller WL; Reid G
    Expert Opin Pharmacother; 2010 Dec; 11(18):2985-95. PubMed ID: 21080853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain Lactobacillus johnsonii NCC933 and vaginal strain Lactobacillus gasseri KS120.1 against enteric, uropathogenic and vaginosis-associated pathogens.
    Atassi F; Servin AL
    FEMS Microbiol Lett; 2010 Mar; 304(1):29-38. PubMed ID: 20082639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacilli for prevention of urogenital infections: a review.
    Marelli G; Papaleo E; Ferrari A
    Eur Rev Med Pharmacol Sci; 2004; 8(2):87-95. PubMed ID: 15267122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
    Castro J; Alves P; Sousa C; Cereija T; França Â; Jefferson KK; Cerca N
    Sci Rep; 2015 Jun; 5():11640. PubMed ID: 26113465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the vaginal microbiota with probiotics as a means to counteract infections.
    Reid G; Dols J; Miller W
    Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):583-7. PubMed ID: 19741517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Lacto- and Bifidobacteria in monoculture on the vaginal microflora in norm and in cases of intravaginal staphylococcosis.
    Babenko LR; Lazarenko LM; Shynkarenko LM; Mokrozub VV; Pidgorskyi VS; Spivak MJ
    Mikrobiol Z; 2013; 75(3):46-55. PubMed ID: 23866586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen peroxide production and resistance to nonoxinol-9 in Lactobacillus spp. isolated from the vagina of reproductive-age women.
    Angeles-López M; García-Cano Ramos E; Aquino Santiago C
    Rev Latinoam Microbiol; 2001; 43(4):171-6. PubMed ID: 17061505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women.
    Matu MN; Orinda GO; Njagi EN; Cohen CR; Bukusi EA
    Anaerobe; 2010 Jun; 16(3):210-5. PubMed ID: 19925874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal Lactobacillus isolates inhibit uropathogenic Escherichia coli.
    Atassi F; Brassart D; Grob P; Graf F; Servin AL
    FEMS Microbiol Lett; 2006 Apr; 257(1):132-8. PubMed ID: 16553843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.